Healthcare, Medtech & Pharma Group
Start-ups: Navigating the course from investment to exit
Wednesday 17 January
This event is supported by RocketSpace
With long development lead-times, a heavy regulatory environment, and challenging market access, it can seem as if healthcare entrepreneurs and their investors face more hurdles than most. Our expert panel will help guide us through the opportunities for entries and exits in this exciting area, at least as they see it. The discussion will be useful for those looking to learn:
• How to mitigate regulatory, commercial and other risks;
• How to raise funding for healthcare ventures at each stage of development from concept to growth to acquisition currency;
• What exit routes work best for the different sectors within healthcare;
• When and how to invest in the sector to maximise returns;
• What does Brexit mean for healthcare start-ups?
RocketSpace is a new co-working space for start-ups and scale-ups that also works with corporate accelerator programmes and investors. It’s based in a former bank vault so come early if you would like a look around this exciting new space.
Christoph Ruedig (MBA 05D) is a partner at Albion Capitalfocusing on healthcare, digital and the UCL technology fund. He originally trained as a radiologist in Germany, and since INSEAD has worked in healthcare for Bain, 3i and GE before joining Albion, where he sits as investor representative on a number of healthcare company boards.
Simon Turton (MBA 00J) is Managing Director of Gensmile, a growing dental group. Prior to INSEAD he got a PhD in pharmacy from the University of London, while afterwards he was involved with Index Ventures, a biotech investment firm, and became head of European healthcare for Warburg Pincus. More recently Simon helped create AIM-listed Midatech PLC, a nanomedicine company focused on the development and commercialisation of targeted therapies for major diseases with unmet medical need.
Justin Walters (MBA 94J) is involved in a number of digital healthcare start-ups, including being chairman of MyClinicalOutcomes, a service that helps hospitals collect, track and benchmark true patient reported outcomes. He is also co-Founder of Ways of Eating, a service designed to help families at risk of Type 2 diabetes and pre-diabetes. Justin is also an advisor to Mumsnet, as well as OC&C.
Moderator: Ted Townsend (MBA 90D) is a self-employed management consultant and author of the LaingBuisson Private Acute Medical Care in Central London report, as well as director of two conferences. His previous experience was in strategy and M&A with Bain, Lazard and Reed Elsevier.
The Yard, off Duncan Street, London N1 8EQ
Nearest tube: Angel
TIME 18:30 for 19:00
COST Members £25 Members’ guests (non-INSEAD) £35
REFRESHMENTS Wine and canapés